Biotech and Pharma
Search documents
Novo Nordisk slashes full-year sales forecast amid competition in diabetes and obesity markets
Proactiveinvestors NA· 2025-11-05 16:24
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
Lisata Therapeutics reports preclinical data showing certepetide's potential to enhance cancer drug delivery
Proactiveinvestors NA· 2025-11-04 21:25
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
Novo Nordisk tops Pfizer in bidding war for obesity startup Metsera
Proactiveinvestors NA· 2025-11-04 17:27
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Protalix and Chiesi seek EMA re-examination of Elfabrio dosing opinion
Proactiveinvestors NA· 2025-11-04 14:00
About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...
Uniqure stock plunges after FDA rejects company's clinical data for Huntington's therapy
Proactiveinvestors NA· 2025-11-03 15:56
About this content About Sean Mason Sean Mason is a Senior Journalist at Proactive, having researched and written about Canadian and US equities for 20 years. Sean graduated from the University of Toronto with a BA in history and economics and has also passed the Canadian Securities Course. He previously worked at Investors Digest of Canada, Stockhouse, and SmallCapPower.com. Read more About the publisher Proactive financial news and online broadcast teams provide fast, accessible, informative and action ...
Amplitude analysts see revenue growth acceleration into next year
Proactiveinvestors NA· 2025-10-31 16:43
Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2][3] - The news team covers key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] - Proactive focuses on medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [2][3] Group 2 - The team delivers insights across various sectors including biotech and pharma, mining and natural resources, battery metals, oil and gas, crypto, and emerging digital and EV technologies [3] - Proactive adopts technology to enhance workflows and improve content production [4][5] - All content published by Proactive is edited and authored by humans, ensuring adherence to best practices in content production and search engine optimization [5]
Thermo Fisher Scientific to acquire Clario in $8.9B cash deal
Proactiveinvestors NA· 2025-10-29 15:22
Group 1 - Proactive provides fast, accessible, informative, and actionable business and finance news content to a global investment audience [2][3] - The news team covers key finance and investing hubs including London, New York, Toronto, Vancouver, Sydney, and Perth [2] - Proactive focuses on medium and small-cap markets while also covering blue-chip companies, commodities, and broader investment stories [2][3] Group 2 - The team delivers news and insights across various sectors including biotech, pharma, mining, natural resources, battery metals, oil and gas, crypto, and emerging technologies [3] - Proactive adopts technology to enhance workflows and improve content production [4][5] - All content published by Proactive is edited and authored by humans, ensuring adherence to best practices in content production and search engine optimization [5]
Anteris Technologies’ DurAVR valve sustains strong one-year performance in small annuli patients
Proactiveinvestors NA· 2025-10-29 12:10
About this content About Lisa Uhlman Lisa Uhlman is an equities reporter at Proactive Investors, covering ASX-listed companies across the mining, energy, biotech and emerging tech sectors. With a background in legal and financial journalism, Lisa brings a sharp analytical lens to market news and corporate developments. Prior to joining Proactive, she reported for national trade publications and newswires, with a focus on court reporting, regulatory affairs and ESG-related business issues. Based in Sydney ...
24/7 Market News- Kraig Labs Eyes Multi-Billion-Dollar Eco-Luxury Apparel Market with Mass-Produced Spider Silk
Globenewswire· 2025-10-29 12:05
DENVER, Oct. 29, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that Kraig Biocraft Laboratories (OTCQB: KBLB), the undisputed global leader in the development and commercialization of spider silk, appears to be positioning itself at the forefront of a potential multi-billion-dollar eco-luxury apparel revolution. With synthetic spider silk production finally reaching meaningful commercial scale, Kra ...
Novartis to acquire Avidity Biosciences in $12B deal
Proactiveinvestors NA· 2025-10-27 13:13
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...